drug

piflufolastat f-18

1 story · latest Aug 6, 2026

Status: FDA approved May 2021 · NDA214793, NDA220089
Brands: Pylarify, Pylarify Truvu

Timeline

Lantheus posts Q2 2026 results, pulls guidance amid pending Curium merger

Aug 6Quarterly updateLantheus Holdings, Inc.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.